A retrospective single-centre cohort study analysing progression and survival of Patients with Idiopathic Pulmonary Fibrosis with preserved lung function on antifibrotic treatment
Latest Information Update: 28 Oct 2020
At a glance
- Drugs Nintedanib (Primary) ; Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions; Therapeutic Use
- 28 Oct 2020 New trial record
- 24 Oct 2020 Results published in the Advances in Therapy